Click here to close now.




















Welcome!

News Feed Item

Applied Biologics LLC Names Edward Britt President

SCOTTSDALE, Ariz., Feb. 6, 2014 /PRNewswire/ -- Applied Biologics LLC, an integrated biotechnology company engaged in the development and commercialization of innovative biologic products derived from the placental tissues, is pleased to announce the appointment of Edward Britt as President.

(Logo: http://photos.prnewswire.com/prnh/20140206/LA60748LOGO)

Since early 2013, Mr. Britt has been an active and engaged part of both the board and the Company. Britt continues his work with the Company as President effective January 15, 2014. As President, Britt will direct all facets of a robust integrated biotechnology companyincluding all development, development services, financing and distribution activities.

"I am honored to have been chosen by the board to lead Applied Biologics into the next exciting era of the Company," said Edward Britt. "Applied Biologics' focus on execution in research, supply chain management, and superior distribution channels has helped to establish us as a leader in placental tissue-derived products. I look forward to working with our executive team, our employees and distribution partners in driving growth for our Company and the entire regenerative medicine technology space."

"Applied Biologics' board of directors is responsible for ensuring the continuity of the Company's senior leadership and that the executive team possesses the experience, skills and character required to achieve the Company's goals. With today's announcement, we enable a smooth transition to a proven executive in Edward Britt, while providing for ongoing guidance and leadership from Jon and Jason, the co-founders. We have the highest degree of confidence that his leadership will further expand Applied Biologics' impressive record of innovation and commercialization of placental-derived products and continued shareholder value creation," said Ian Vasquez, Director of Operations.

Mr. Wakefield will continue to guide the Company's future strategies and direction. "I am very proud of what we have accomplished during my time as President, and speaking on behalf of the Company co-founders, we look forward to being part of the Company's continued success. At its heart, Applied Biologics is a company of innovators and entrepreneurs and I'm excited by the opportunities that lay ahead," Wakefield said. "I want to congratulate Edward on his new role. Having worked with him for the last year in the Company, I have the utmost confidence in Edward and in the rest of the management team that they will continue to drive technical and business innovations, ensuring the growth and future of Applied Biologics. I very much look forward to continuing to work with Edward in his role as President."

About Applied Biologics LLC
Applied Biologics LLC is a global leader in advancing regenerative medicine through the research, translational biotechnology, development and commercialization of placental-tissue derived products, including, but not limited to FloGraft® and XWRAP®. All of our allograft is procured from consenting donors through a scheduled, full-term Caesarean section birth without fetal sacrifice or harm. Amniotic membrane and fluid offer a rich source of native organic cellular components that deserve extensive research to explore their full potential. Immune privilege is a unique characteristic that differentiates this human allograft from other tissue sources. Applied Biologics is focused on optimizing the regenerative potential of this unique allograft. Since 2010, Applied Biologics has been an industry leader in providing innovative amnion-technology for management of soft-tissue defects, orthopedic procedures, sports medicine, chronic wounds, and nerve, ligament and tendon defects. For more information, please visit: www.appliedbiologics.com.

Applied Biologics Forward-looking Statement

This publication may include "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Applied Biologics' management and are subject to significant risks and uncertainties. Applied Biologics undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.Accordingly, all written or oral forward-looking statements attributable to Applied Biologics, LLC are qualified by this caution.

SOURCE Applied Biologics LLC

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Skeuomorphism usually means retaining existing design cues in something new that doesn’t actually need them. However, the concept of skeuomorphism can be thought of as relating more broadly to applying existing patterns to new technologies that, in fact, cry out for new approaches. In his session at DevOps Summit, Gordon Haff, Senior Cloud Strategy Marketing and Evangelism Manager at Red Hat, discussed why containers should be paired with new architectural practices such as microservices rathe...
SYS-CON Events announced today that G2G3 will exhibit at SYS-CON's @DevOpsSummit Silicon Valley, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Based on a collective appreciation for user experience, design, and technology, G2G3 is uniquely qualified and motivated to redefine how organizations and people engage in an increasingly digital world.
Any Ops team trying to support a company in today’s cloud-connected world knows that a new way of thinking is required – one just as dramatic than the shift from Ops to DevOps. The diversity of modern operations requires teams to focus their impact on breadth vs. depth. In his session at DevOps Summit, Adam Serediuk, Director of Operations at xMatters, Inc., will discuss the strategic requirements of evolving from Ops to DevOps, and why modern Operations has begun leveraging the “NoOps” approa...
Too often with compelling new technologies market participants become overly enamored with that attractiveness of the technology and neglect underlying business drivers. This tendency, what some call the “newest shiny object syndrome,” is understandable given that virtually all of us are heavily engaged in technology. But it is also mistaken. Without concrete business cases driving its deployment, IoT, like many other technologies before it, will fade into obscurity.
Organizations from small to large are increasingly adopting cloud solutions to deliver essential business services at a much lower cost. According to cyber security experts, the frequency and severity of cyber-attacks are on the rise, causing alarm to businesses and customers across a variety of industries. To defend against exploits like these, a company must adopt a comprehensive security defense strategy that is designed for their business. In 2015, organizations such as United Airlines, Sony...
The Internet of Things is in the early stages of mainstream deployment but it promises to unlock value and rapidly transform how organizations manage, operationalize, and monetize their assets. IoT is a complex structure of hardware, sensors, applications, analytics and devices that need to be able to communicate geographically and across all functions. Once the data is collected from numerous endpoints, the challenge then becomes converting it into actionable insight.
Puppet Labs has announced the next major update to its flagship product: Puppet Enterprise 2015.2. This release includes new features providing DevOps teams with clarity, simplicity and additional management capabilities, including an all-new user interface, an interactive graph for visualizing infrastructure code, a new unified agent and broader infrastructure support.
Consumer IoT applications provide data about the user that just doesn’t exist in traditional PC or mobile web applications. This rich data, or “context,” enables the highly personalized consumer experiences that characterize many consumer IoT apps. This same data is also providing brands with unprecedented insight into how their connected products are being used, while, at the same time, powering highly targeted engagement and marketing opportunities. In his session at @ThingsExpo, Nathan Trel...
Amazon and Google have built software-defined data centers (SDDCs) that deliver massively scalable services with great efficiency. Yet, building SDDCs has proven to be a near impossibility for ‘normal’ companies without hyper-scale resources. In his session at 17th Cloud Expo, David Cauthron, founder and chief executive officer of Nimboxx, will discuss the evolution of virtualization (hardware, application, memory, storage) and how commodity / open source hyper converged infrastructure (HCI) so...
In their Live Hack” presentation at 17th Cloud Expo, Stephen Coty and Paul Fletcher, Chief Security Evangelists at Alert Logic, will provide the audience with a chance to see a live demonstration of the common tools cyber attackers use to attack cloud and traditional IT systems. This “Live Hack” uses open source attack tools that are free and available for download by anybody. Attendees will learn where to find and how to operate these tools for the purpose of testing their own IT infrastructu...
The web app is agile. The REST API is agile. The testing and planning are agile. But alas, data infrastructures certainly are not. Once an application matures, changing the shape or indexing scheme of data often forces at best a top down planning exercise and at worst includes schema changes that force downtime. The time has come for a new approach that fundamentally advances the agility of distributed data infrastructures. Come learn about a new solution to the problems faced by software organ...
With the Apple Watch making its way onto wrists all over the world, it’s only a matter of time before it becomes a staple in the workplace. In fact, Forrester reported that 68 percent of technology and business decision-makers characterize wearables as a top priority for 2015. Recognizing their business value early on, FinancialForce.com was the first to bring ERP to wearables, helping streamline communication across front and back office functions. In his session at @ThingsExpo, Kevin Roberts...
IBM’s Blue Box Cloud, powered by OpenStack, is now available in any of IBM’s globally integrated cloud data centers running SoftLayer infrastructure. Less than 90 days after its acquisition of Blue Box, IBM has integrated its Blue Box Cloud Dedicated private-cloud-as-a-service into its broader portfolio of OpenStack® based solutions. The announcement, made today at the OpenStack Silicon Valley event, further highlights IBM’s continued support to deliver OpenStack solutions across all cloud depl...
Red Hat is investing in Tesora, the number one contributor to OpenStack Trove Database as a Service (DBaaS) also ranked among the top 20 companies contributing to OpenStack overall. Tesora, the company bringing OpenStack Trove Database as a Service (DBaaS) to the enterprise, has announced that Red Hat and others have invested in the company as a part of Tesora's latest funding round. The funding agreement expands on the ongoing collaboration between Tesora and Red Hat, which dates back to Febr...
With the proliferation of connected devices underpinning new Internet of Things systems, Brandon Schulz, Director of Luxoft IoT – Retail, will be looking at the transformation of the retail customer experience in brick and mortar stores in his session at @ThingsExpo. Questions he will address include: Will beacons drop to the wayside like QR codes, or be a proximity-based profit driver? How will the customer experience change in stores of all types when everything can be instrumented and a...